We are a biotech company focused on precision oncology.
We believe that every cancer patient deserves targeted drugs tailored to their specific disease as closely as possible. Find out what else makes us tick.
)
The company Meet your new partner in therapeutics development.
For nearly 25 years, we have been pursuing a single, overarching vision: a world in which precision therapy offers a cure for every cancer patient. To get closer to our vision, we have specialized in discovering novel targets, utilizing an approach based on unique high-quality cancer data, combining molecular, biological, technological, and pharmacological knowledge. Learn more about our mission, meet the leading minds of Indivumed, and explore the most important milestones of our history.
Two powerful networks to boost oncology innovation
As one of the leading precision oncology companies, we recognize that true progress will only come from joining forces. From research to therapy, we are all part of the same team.
)
Onco AI-Med is a global alliance of leading oncologists and cancer researchers built on decades of scientific collaboration with Indivumed. Its members are united by their mutual commitment to advancing precision oncology, sharing ideas and expertise across disciplines to accelerate progress. Guided by an advisory board of leading experts in translational and clinical oncology, the network fosters innovation and collaboration to improve outcomes for cancer patients worldwide.
)
Through our network of renowned international cancer clinics, we have access to biospecimens and data with a wide variety of biological backgrounds from all over the world. Together, we have created unique protocols and procedures to collect tissue of unmatched quality and variety, setting a new gold standard for extracting multi-omics cancer data. Adhering to these standards is essential to making all relevant details of a cancer disease transparent.
:format(webp))
Our mission is to advance the development of precision oncology drugs.
)
CareerWe believe in the power of people.
Our ultimate goal is to enable highly specific therapies for cancer patients worldwide. Driven by a pioneering spirit and a shared purpose, we explore the complexity of cancer with curiosity and determination to expand the possibilities of precision oncology. Our team is as diverse as the challenges we tackle – a diversity that drives our innovation and makes us stronger as a group.